Literature DB >> 30056355

Comparison of intramyometrial vasopressin plus rectal misoprostol with intramyometrial vasopressin alone to decrease blood loss during laparoscopic myomectomy: Randomized clinical trial.

Sonal Srivastava1, Reeta Mahey2, Garima Kachhawa1, Neerja Bhatla1, Ashish Datt Upadhyay1, Alka Kriplani1.   

Abstract

OBJECTIVE: To compare the efficacy and safety of intramyometrial vasopressin plus rectal misoprostol with intramyometrial vasopressin alone to reduce blood loss during laparoscopic myomectomy. STUDY
DESIGN: A randomized, single-blind, controlled trial was conducted at All India Institute of Medical Sciences, New Delhi, India. Sixty women with symptomatic leiomyoma scheduled for laparoscopic myomectomy were recruited for the study. Thirty women received intramyometrial vasopressin plus rectal misoprostol (30 min before procedure) (Group I) and 30 women received intramyometrial vasopressin alone (Group II) during laparoscopic myomectomy. The primary outcome measure was intra-operative blood loss during surgery. Secondary outcome measures included decrease in postoperative haemoglobin, ease of enucleation of myomas, duration of surgery, need for additional haemostatic measures or blood transfusion, intra- and postoperative morbidity, and duration of hospital stay.
RESULTS: The baseline demographic features and characteristics of leiomyomas were comparable in both groups. The mean (±standard deviation) blood loss in Group I was 139 ± 96.7 ml, which was significantly less than that for Group II (206 ± 101.2 ml) (p = 0.008). The mean postoperative haemoglobin was 11.6 ± 1.3 g/dl in Group I and 10.0 ± 1.2 g/dl in Group II (p = 0.001). Although blood loss was not clinically significant in either group, the decrease in haemoglobin was significantly higher in Group II. The mean score for ease of enucleation (surgeon-rated measure) was significantly lower in Group I (2.6 ± 1.1) compared with Group II (3.4 ± 1.1) (p = 0.029). Intra- and postoperative vital signs, duration of surgery, need for blood transfusion and postoperative morbidity were comparable in both groups.
CONCLUSIONS: The addition of rectal misoprostol to intramyometrial vasopressin led to a significant reduction in blood loss and decreased the postoperative drop in haemoglobin. The combination also improved the ease of enucleation of myomas.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Laparoscopy; Misoprostol; Myomectomy; Vasopressin

Mesh:

Substances:

Year:  2018        PMID: 30056355     DOI: 10.1016/j.ejogrb.2018.07.006

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Robot-Assisted Laparoscopic Myomectomy versus Abdominal Myomectomy for Large Myomas Sized over 10 cm or Weighing 250 g.

Authors:  Sa Ra Lee; Eun Sil Lee; Young Jae Lee; Shin Wha Lee; Jeong Yeol Park; Dae Yeon Kim; Sung Hoon Kim; Yong Man Kim; Dae Shik Suh; Young Tak Kim
Journal:  Yonsei Med J       Date:  2020-12       Impact factor: 2.759

2.  New Surgical Technique for Robotic Myomectomy: Continuous Locking Suture on Myoma (LSOM) Technique.

Authors:  Sa Ra Lee; Eun Sil Lee; Hye Lim Eum; Young-Jae Lee; Shin-Wha Lee; Jeong Yeol Park; Dae-Shik Suh; Dae-Yeon Kim; Sung Hoon Kim; Yong-Man Kim; Young-Tak Kim
Journal:  J Clin Med       Date:  2021-02-08       Impact factor: 4.241

3.  A Romanian study on the impact of glypressin in laparoscopic myomectomy.

Authors:  Daniela Roxana Matasariu; Alexandra Ursache; Loredana Himiniuc; Bogdan Toma; Vasile Lucian Boiculese; Dorina Rudisteanu; Irina Dumitrascu
Journal:  Exp Ther Med       Date:  2021-07-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.